Search Details

Word: mckeen (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...largest ethical drug company, followed the overseas route to executive leadership. As its new president and chief executive officer, it picked John J. Powers, 52, the chief of its international operations for the past 14 years. Powers takes over as Pfizer's boss from John E. McKeen, 61, who will retain his position as chairman...

Author: /time Magazine | Title: Management: Internationalism at the top | 5/14/1965 | See Source »

...Five-by-Five. McKeen had clearly prescribed the right medicine: the company last year set profit records for the eleventh consecutive year. With 68 plants scattered around the world-and ten more planned for the next year or two-it is now one of the world's top producers of animal medicines and feed supplements and of chemical additives for food and beverages. It is the third largest company in the U.S. fragrance market and in the manufacture of lipsticks. Overseas sales have grown so fast that they now account for nearly half of Pfizer's total, have...

Author: /time Magazine | Title: Drugs: The Little Company That Got Well | 8/7/1964 | See Source »

...chemical engineer who began his career at Pfizer as a $25-a-week control chemist, McKeen has surrounded himself with bright executives and given them complete authority to make their own decisions. He has set a goal that everyone in the company knows as "five by five"-$500 million in sales for Pfizer...

Author: /time Magazine | Title: Drugs: The Little Company That Got Well | 8/7/1964 | See Source »

...courts. Charging conspiracy to fix prices and limit competition, the Justice Department won a grand jury antitrust indictment against three of the nation's largest antibiotic producers and their chief executives. The defendants: American Cyanamid and its chairman, Wilbur G. Malcolm; Charles Pfizer & Co. and Chairman John E. McKeen; Bristol-Myers Co. and President Frederic N. Schwartz...

Author: /time Magazine | Title: Public Policy: Antitrust & Antibiotics | 8/25/1961 | See Source »

...drug companies could draw fines of up to $150,000 each, and their chief executives would be liable to as much as a year in jail plus $50,000 fines. But the embattled drug executives clearly had no intention of surrendering without a fight. Snapped Pfizer's McKeen: "The charges are positively not true." Said Cyanamid's Malcolm: "Harassment." And Bristol-Myers' Schwartz promised: "This action will be vigorously defended...

Author: /time Magazine | Title: Public Policy: Antitrust & Antibiotics | 8/25/1961 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Next